Lactobacillus paracasei – LPC09 (DSM 24243)

Tabella dei contenuti

Clinical indications

antipathogenic activity, Cystitis, kidney stones

Area of use

Urology blend | Kidney stones

  • Lactobacillus plantarum – LP01 (LMG P-21021)
  • Lactobacillus paracasei – LPC09 (DSM 24243)

Characteristics

FUNCTIONALITY
1) LP01 2.5 billion + LPC09 1 billion


FUNCTIONALITY
Cystitis • Inhibition of E. coli • Metabolization of oxalates, prevention of kidney stones

Scientific support

Clinical study
Vicariotto F. Effectiveness of An Association of a Cranberry Dry Extract, D-Mannose, and the 2 Microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in Women Affected by Cystitis. Journal of Clin Gastroenterol 2014;48:S96-S101.

In vitro studies
a) Mogna L. et al. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains. J Clin Gastroenterol. 2012; 46 Suppl:S29-32.
b) Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? J Clin Gastroenterol. 2014; 48 Suppl:S91-95.

+ Internal data on anti-inflammatory and anti-oxidant properties available upon request


Urology blend | UTI

  • Lactobacillus plantarum – LP01 (LMG P-21021)
  • Lactobacillus paracasei – LPC09 (DSM 24243)

Characteristics

FUNCTIONALITY
1) LP01 2.5 billion + LPC09 1 billion


FUNCTIONALITY
UTI • Inhibition of E. coli • Anti-inflammatory • Metabolization of oxalates, prevention of kidney stones

Scientific support

Clinical study
Vicariotto F. Effectiveness of An Association of a Cranberry Dry Extract, D-Mannose, and the 2 Microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in Women Affected by Cystitis. Journal of Clin Gastroenterol 2014;48:S96-S101.

In vitro studies
a) Mogna L. et al. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains. J Clin Gastroenterol. 2012; 46 Suppl:S29-32.
b) Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? J Clin Gastroenterol. 2014; 48 Suppl:S91-95.

+ Internal data on anti-inflammatory and anti-oxidant properties available upon request


Urology strain | Kidney stones

Characteristics

FUNCTIONALITY
Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence

Scientific support

In vitro studies
Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? (LPC09, LA02, LP01, LRE02, BR03, BL03) J Clin Gastroenterol. 2014; 48 Suppl:S91-95.

+ Internal data on anti-inflammatory and anti-oxidant properties available upon request on certain strains

Clinical studies on-going on LP01+LPC09+Bb1 and other actives in prostate health